(Q84854217)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

A live bivalent influenza vaccine based on a H9N2 virus strain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

Rui Wu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Zhongdong Yang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jianjun Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Hanzhong Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Quanjiao Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Zhiwei Sui

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Fang Fang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Ze Chen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

3 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

673-680

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

Novel generations of influenza vaccines

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Influenza vaccines: present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Live attenuated vaccines against influenza; an historical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Unpacking the incoming influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Influenza virus M2 protein has ion channel activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

The morphology and composition of influenza A virus particles are not affected by low levels of M1 and M2 proteins in infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Generation of recombinant influenza A virus without M2 ion-channel protein by introduction of a point mutation at the 5' end of the viral intron.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Universal primer set for the full-length amplification of all influenza A viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

A DNA transfection system for generation of influenza A virus from eight plasmids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Generation of influenza A viruses entirely from cloned cDNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Introduction of site-specific mutations into the genome of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Chimeric influenza virus replicating predominantly in the murine upper respiratory tract induces local immune responses against human immunodeficiency virus type 1 in the genital tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

7 January 2021

Influenza virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Development of novel influenza virus vaccines and vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Negative-strand RNA viruses: genetic engineering and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5' terminal sequence: induction of heterospecific B and T cell responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Amplification, expression, and packaging of foreign gene by influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5' end of the PB2 segment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Membrane-anchored incorporation of a foreign protein in recombinant influenza virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Live bivalent vaccine for parainfluenza and influenza virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Rescue of influenza virus expressing GFP from the NS1 reading frame

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

inferred from DOI database lookup

7 January 2021

based on heuristic

Mechanism of attenuation of a chimeric influenza A/B transfectant virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression of a foreign protein by influenza A virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.102

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.10.102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19892041%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference